Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-03

FDA Approved: EXEMESTANE — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves the original application for Exemestane as a generic drug, manufactured by Zydus Pharmaceuticals USA Inc., for the treatment of breast cancer in po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exemestane (Exemestane)

Snippet

ORIG AP for EXEMESTANE (EXEMESTANE)